MEDIROM MOTHER Labs Surpasses 100 Business Contracts and Supports Over 10,000 Individuals with "Lav" App

Reuters
05-30
MEDIROM MOTHER Labs Surpasses 100 Business Contracts and Supports Over 10,000 Individuals with "Lav" App

MEDIROM Healthcare Technologies Inc.'s subsidiary, MEDIROM MOTHER Labs, Inc., has achieved significant milestones with its specific health guidance service utilizing the "Lav" healthcare app. Since its launch in 2019, the service has garnered over 100 contracted companies and supported more than 10,000 individuals. The app provides continuous health support through information and communication technology, receiving high praise from health insurance associations and company employees. The initiative is part of a broader effort to prevent lifestyle-related diseases and promote health management, aiming to establish healthy behaviors through diet and exercise guidance. As of April 2025, approximately 1 out of every 14 health insurance associations in Japan is a partner of the "Lav" app.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008263), on May 30, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10